Second Vir-GSK monoclonal antibody to enter Phase 1/2 COVID-19 trials Vir Biotechnology and GSK will evaluate VIR-7832 in the early treatment of COVID-19 in a Phase 1b/2a trial starting in the first quarter of this year.
Preclinical data suggests VIR-7832, a neutralising COVID-19 antibody, has two distinguishing properties: an enhanced ability to clear infected cells and the potential to enhance virus-specific T cell function, which could help treat and/or prevent COVID-19 infection.
California’s Vir Biotechnology and GSK entered into a coronavirus collaboration in April 2020: using Vir’s proprietary monoclonal antibody platform tech to identify new and existing anti-viral antibodies for use against the COVID-19 pandemic. VIR-7832 is the second monoclonal antibody from the collaboration.
Covid-19 infection grants immunity for five months, UK study suggests cnn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnn.com Daily Mail and Mail on Sunday newspapers.
Germany s record death toll is very worrying, says infectious disease institute chief
From CNN s Nadine Schmidt in Berlin
Employees move coffins at a crematorium in Meissen, Germany on January 13. Jens Schlueter/AFP/Getty Images
The number of coronavirus fatalities in Germany is very worrying, the head of the Robert Koch Institute for infectious diseases (RKI) said Thursday, as the country reported its highest single-day pandemic death toll of 1,244.
New Covid-19 infections must reduce massively, Lothar Wieler told journalists in Berlin, adding that intensive care units have never been as exhausted as in recent days.” There are now 5,200 patients being treated in German ICUs with 90% on ventilation.
Natural Immunity From COVID-19 May Last Months medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Long Covid sufferers fight for help and recognition
Complete exhaustion, also accompanied by muscle weakness, is the most common symptom of Long Covid. Credit: Mariia Boiko / Alamy Stock Photo
Since March last year, the Covid-19 pandemic has been at the forefront of everyone’s minds. Whilst most of those that get sick recover quickly from mild flu-like symptoms, the virus has also brought another disease that is still barely on the radar of governments, authorities and doctors: Long Covid.
This content was published on January 13, 2021 - 11:00
January 13, 2021 - 11:00
Renat Kuenzi
Studied history and politics at University of Bern. Worked at Reuters, the newspapers Der Bund and Berner Zeitung, and the Förderband radio station. I am concerned with the Swiss practice of modern direct democracy in all its aspects and at all levels, my constant focus being the citizen.